Cadrenal Therapeutics
(NASDAQ) CVKD
Cadrenal Therapeutics Financials at a Glance
Market Cap
$10.83M
Revenue (TTM)
$0.00
Net Income (TTM)
$13.24M
EPS (TTM)
$-6.68
P/E Ratio
-0.65
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.98
Volume
1,553
Open
$4.87
Price
$4.98
Volume
1,553
Open
$4.87
Previous Close
$4.98
Daily Range
$4.86 - $5.18
52-Week Range
$4.21 - $17.50
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.98
Volume
1,553
Open
$4.87
Previous Close
$4.98
Daily Range
$4.86 - $5.18
52-Week Range
$4.21 - $17.50
CVKD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cadrenal Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
5
CEO
Quang X. Pham
Website
www.cadrenal.comHeadquarters
Ponte Vedra, FL 32082, US
CVKD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-260%
Return on Capital
-5%
Return on Assets
-3%
Earnings Yield
-1.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.83M
Shares Outstanding
2.51M
Volume
1.55K
Short Interest
0.00%
Avg. Volume
50.43K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$13.46M
EBITDA
$13.46M
Operating Cash Flow
$12.60M
Capital Expenditure
$5.10K
Free Cash Flow
$12.60M
Cash & ST Invst.
$4.01M
Total Debt
$0.00
Cadrenal Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$10.83M
N/A
Market Cap/Employee
$2.71M
N/A
Employees
4
N/A
Net Income
$3.04M
+27.4%
EBITDA
$3.07M
+26.8%
Quarterly Fundamentals
Net Cash
$4.01M
-60.0%
Accounts Receivable
$5.10K
-86.6%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-3.06%
N/A
Return on Invested Capital
-4.92%
N/A
Free Cash Flow
$2.57M
-43.2%
Operating Cash Flow
$2.57M
-43.5%